- Home
- ZIP vs ARCT Comparison
ZIP vs ARCT Comparison
Compare ZIP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIP | ARCT |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 295.1M | 245.4M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZIP | ARCT |
|---|---|---|
| Price | $3.05 | $7.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $3.88 | ★ $24.11 |
| AVG Volume (30 Days) | ★ 770.6K | 402.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $448,952,000.00 | $82,031,000.00 |
| Revenue This Year | $1.00 | N/A |
| Revenue Next Year | $5.93 | $12.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.65 | $5.85 |
| 52 Week High | $6.55 | $24.14 |
Technical Indicators
Market Signals| Indicator | ZIP | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 39.76 |
| Support Level | $2.77 | $6.90 |
| Resistance Level | $3.08 | $7.88 |
| Average True Range (ATR) | 0.36 | 0.61 |
| MACD | -0.07 | -0.20 |
| Stochastic Oscillator | 18.05 | 18.35 |
Price Performance
Historical ComparisonAbout ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace that connects job seekers and employers through an AI-powered platform. The company provides recruiting solutions that help employers identify and hire qualified candidates while enabling job seekers to discover relevant job opportunities through intelligent matching and recommendation tools.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.